Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jcrc.2020.07.023 http://scihub22266oqcxt.onion/10.1016/j.jcrc.2020.07.023 32777758!7386261!32777758     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Crit+Care 2020 ; 60 (ä): 91-95 Nephropedia Template TP {{tp|p=32777758|t=2020. What every Intensivist should know about COVID-19 associated acute kidney injury |pdf=|usr=}}{{32777758}} gab.com Text What every Intensivist should know about COVID-19 associated acute kidney injury JO: J Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=32777758 #FOAvip Acute kidney injury (AKI) is a serious complication in critically ill patients with COVID-19 with a reported incidence ranging from <5% to >25%. Proposed aetiologies include hypovolemia, hemodynamic disturbance and inflammation but also specific factors like direct viral invasion, microvascular thrombosis, and altered regulation of the renin-angiotensin-aldosterone system. To date, there are no confirmed specific therapies, and prevention and management of AKI should follow established guidelines. Novel therapies specifically targeting COVID-19 related pathologies are under investigation. The incidence of renal replacement therapy (RRT) is variable, ranging from 0-37%. In a pandemic, RRT practice is likely to be determined by the number of patients, availability of machines, consumables and staff, clinical expertise, and acceptable alternatives. Close collaboration between critical care and renal services is essential. In this article, we describe the epidemiology and pathophysiology of COVID-19 associated AKI, outline current management and suggest strategies to provide RRT during a pandemic when resources may be scarce. Twit Text FOAVip What every Intensivist should know about COVID-19 associated acute kidney injury ????J Crit Care http://www.kidney.de/pget.php?&tw=1&pmid=32777758 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32777758 #FOAvip English Wikipedia <ref>{{Cite pmid|32777758}}</ref> What every Intensivist should know about COVID-19 associated acute kidney injury #MMPMID32777758 Ostermann M; Lumlertgul N; Forni LG; Hoste E J Crit Care 2020[Dec]; 60 (ä): 91-95 PMID32777758show ga Acute kidney injury (AKI) is a serious complication in critically ill patients with COVID-19 with a reported incidence ranging from <5% to >25%. Proposed aetiologies include hypovolemia, hemodynamic disturbance and inflammation but also specific factors like direct viral invasion, microvascular thrombosis, and altered regulation of the renin-angiotensin-aldosterone system. To date, there are no confirmed specific therapies, and prevention and management of AKI should follow established guidelines. Novel therapies specifically targeting COVID-19 related pathologies are under investigation. The incidence of renal replacement therapy (RRT) is variable, ranging from 0-37%. In a pandemic, RRT practice is likely to be determined by the number of patients, availability of machines, consumables and staff, clinical expertise, and acceptable alternatives. Close collaboration between critical care and renal services is essential. In this article, we describe the epidemiology and pathophysiology of COVID-19 associated AKI, outline current management and suggest strategies to provide RRT during a pandemic when resources may be scarce. |*Renal Replacement Therapy[MESH] |Acute Kidney Injury/*complications/diagnosis/virology[MESH] |Aldosterone/metabolism[MESH] |Anticoagulants/therapeutic use[MESH] |COVID-19/*complications/diagnosis[MESH] |Critical Care/*methods[MESH] |Critical Illness[MESH] |Humans[MESH] |Inflammation[MESH] |Microcirculation[MESH] |Pandemics[MESH] |Renin-Angiotensin System[MESH] |Rhabdomyolysis/virology[MESH] |Thrombosis/virology[MESH]What every Intensivist should know about COVID-19 associated acute kid(epmc).pdf DeepDyve Pubget Overpricing